A comparison of pregnancy-specific risk scoring systems for venous thromboembolic pharmacoprophylaxis in hospitalized maternity patients

Comparison of risk assessments for venous thromboembolism during the puerperium

“…We found that the recommended drug prevention rate of the RCOG assessment scale for the VTE group was 76.36% [ 6 ], and the drug prevention rate for the control group was 44.24%, which are similar to the results of previous studies. Daniela et al used the RCOG assessment scale to evaluate 638 women without puerperal VTE, and the proportion of recommended drug prophylaxis was 53% [ 15 ]. This high drug prevention rate in the control group may lead to the use of low molecular weight heparin.…”

Venous Thromboembolism Risk Assessment Models in Obstetrics: A Review of Current Practices and Future Directions

“…A more circumspect and data-driven approach to the utilization of thromboprophylaxis can maintain benefits of VTE prevention while simultaneously avoiding potential prophylaxis-associated morbidities, such as postpartum hemorrhage, heparin-induced thrombocytopenia (HIT), and the reduction in access to regional anesthesia during labor. 32…”

“…A more circumspect and data-driven approach to the utilization of thromboprophylaxis can maintain benefits of VTE prevention while simultaneously avoiding potential prophylaxis-associated morbidities, such as postpartum hemorrhage, heparin-induced thrombocytope-nia (HIT), and the reduction in access to regional anesthesia during labor. 32 A meta-analysis in 2020 conveyed the need to re-evaluate currently used RAMs for VTE in hospitalized patients. Although not tailored to the obstetric population, the study demonstrates that multiple VTE-associated risk factors are still not incorporated into current RAMs, consequently reducing the models' predictive accuracy.…”